Pfizer recalls anti-smoking drug Chantix for potential risk of cancer

News 07/22/21, 00:08

Pfizer, the influential pharmaceutical corporation, is recalling 12 batches of Chantix, a popular anti-smoking medication, after detecting excessive levels of a chemical linked to cancer. The Food and Drug Administration (FDA) on July 19 released a statement to inform that Pfizer has widened the voluntary recall of Chantix, or varenicline, to ...

End of content

No more pages to load